The point mutation of TP53 at the amino acid residue R428 (R248Q), with gain-of-function activity, gives rise to malignant activity in lung cancer cells [161] and a loss of tumor suppressor function in AML [162]. This evidence concerns the gene TP53 and acute myeloid leukemia.